Ying Xia Selected Research

Opioid Receptors (Opioid Receptor)

1/2022	Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.
1/2022	A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress.
1/2021	Alleviation of TGF-β1 induced tubular epithelial-mesenchymal transition via the δ-opioid receptor.
11/2020	δ-opioid receptor activation protects against Parkinson's disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy.
1/2020	δ-Opioid Receptors, microRNAs, and Neuroinflammation in Cerebral Ischemia/Hypoxia.
5/2019	δ-Opioid Receptor Activation Attenuates the Oligomer Formation Induced by Hypoxia and/or α-Synuclein Overexpression/Mutation Through Dual Signaling Pathways.
1/2019	The δ-Opioid Receptor Differentially Regulates MAPKs and Anti-inflammatory Cytokines in Rat Kidney Epithelial Cells Under Hypoxia.
1/2019	δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury.
1/2017	Characteristic MicroRNA Expression Induced by δ-Opioid Receptor Activation in the Rat Liver Under Prolonged Hypoxia.
8/2016	Cytoprotection against Hypoxic and/or MPP⁺ Injury: Effect of δ-Opioid Receptor Activation on Caspase 3.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Xia Research Topics

Disease

38	Hypoxia (Hypoxemia) 01/2022 - 06/2002
33	Neoplasms (Cancer) 01/2022 - 08/2005
17	Inflammation (Inflammations) 10/2022 - 11/2006
13	Ischemia 01/2022 - 06/2008
13	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2012
9	Infections 05/2022 - 04/2014
9	Infarction (Infarctions) 01/2021 - 01/2007
8	Carcinogenesis 01/2021 - 07/2003
8	Breast Neoplasms (Breast Cancer) 11/2019 - 02/2014
7	Cognitive Dysfunction 10/2022 - 04/2012
7	Wounds and Injuries (Trauma) 01/2022 - 08/2006
7	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2010
7	Ischemic Stroke 07/2020 - 04/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2016
6	Brain Injuries (Brain Injury) 12/2016 - 12/2011
6	Lung Neoplasms (Lung Cancer) 01/2009 - 03/2002
5	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 09/2016
5	Brain Ischemia (Cerebral Ischemia) 01/2020 - 08/2008
5	Hepatocellular Carcinoma (Hepatoma) 09/2019 - 01/2014
5	Hypertrophy 07/2015 - 11/2004
4	Epilepsy (Aura) 10/2022 - 12/2005
4	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 04/2012
4	Non-alcoholic Fatty Liver Disease 10/2022 - 07/2020
4	Dementia (Dementias) 10/2022 - 01/2021
4	Fibrosis (Cirrhosis) 01/2022 - 01/2007
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2019
4	Adenocarcinoma 01/2021 - 02/2007
4	Myocardial Infarction 01/2021 - 01/2007
4	Reperfusion Injury 01/2021 - 08/2008
4	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2020 - 11/2009
4	Stroke (Strokes) 08/2019 - 07/2003
4	Leukemia 01/2019 - 08/2005
4	Poisoning 02/2009 - 08/2005
3	Acute Kidney Injury (Acute Renal Failure) 08/2022 - 01/2016
3	Atrophy 01/2022 - 12/2019
3	Glioma (Gliomas) 01/2022 - 01/2017
3	Neuroinflammatory Diseases 01/2021 - 04/2018
3	Cicatrix (Scar) 11/2020 - 06/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2019 - 12/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2017
3	Experimental Arthritis 01/2018 - 01/2015
3	Carcinoma (Carcinomatosis) 01/2013 - 10/2006
3	Heart Failure 08/2007 - 05/2002
2	Weight Gain 10/2022 - 03/2019
2	Hypersensitivity (Allergy) 09/2022 - 01/2019
2	Cardiotoxicity 06/2022 - 09/2011

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2003
20	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 06/2002
15	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2005
12	Messenger RNA (mRNA)IBA 01/2022 - 04/2006
11	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2012
10	CytokinesIBA 01/2022 - 11/2009
10	Pharmaceutical PreparationsIBA 01/2021 - 04/2014
10	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2007
10	Oxygen (Dioxygen)IBA 01/2020 - 02/2007
10	delta Opioid Receptors (delta Opioid Receptor)IBA 12/2018 - 07/2005
9	Phosphotransferases (Kinase)IBA 10/2022 - 08/2006
9	2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acid (1H- benzimidazol- 2- yl)(carboxymethyl)methylamideIBA 01/2022 - 01/2012
9	naltrindoleIBA 01/2019 - 06/2002
8	Long Noncoding RNAIBA 01/2022 - 01/2017
6	Amyloid (Amyloid Fibrils)IBA 10/2022 - 07/2008
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 10/2011
6	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2012
6	EnzymesIBA 04/2020 - 09/2008
6	Mitogen-Activated Protein KinasesIBA 01/2019 - 08/2009
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2010
5	Conditioned Culture MediaIBA 01/2020 - 07/2009
4	LipidsIBA 10/2022 - 12/2021
4	chromium hexavalent ionIBA 06/2022 - 01/2014
4	PrionsIBA 05/2022 - 10/2020
4	AntioxidantsIBA 05/2022 - 08/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2010
4	LigandsIBA 01/2021 - 02/2007
4	Biological ProductsIBA 01/2021 - 07/2011
4	RNA (Ribonucleic Acid)IBA 03/2018 - 08/2006
4	Aldehyde DehydrogenaseIBA 11/2017 - 02/2014
4	Benzene (Benzole)IBA 02/2009 - 08/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2006
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2017
3	Protein Kinases (Protein Kinase)IBA 12/2021 - 05/2004
3	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 12/2015
3	Therapeutic UsesIBA 12/2020 - 01/2012
3	Opioid Analgesics (Opioids)IBA 07/2019 - 11/2009
3	CollagenIBA 01/2017 - 07/2009
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2015 - 08/2008
3	Benzo(a)pyreneIBA 01/2013 - 06/2007
3	TeaIBA 01/2013 - 08/2008
3	Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA 11/2011 - 04/2006
3	ChemokinesIBA 05/2010 - 11/2006
3	Complementary DNA (cDNA)IBA 08/2005 - 08/2005
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2022 - 01/2021
2	AntigensIBA 09/2022 - 01/2021

Therapy/Procedure

30	Therapeutics 10/2022 - 10/2006
8	Drug Therapy (Chemotherapy) 01/2021 - 02/2011
5	Electroacupuncture 01/2020 - 12/2011
4	Transplantation 12/2019 - 07/2003
3	Acupuncture Points (Acupuncture Point) 01/2020 - 01/2013
3	Oral Administration 03/2016 - 08/2008
2	Artificial Respiration (Mechanical Ventilation) 08/2022 - 01/2018